The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
Autor: | de Haas SL, Franson KL, Schmitt JA, Cohen AF, Fau JB, Dubruc C, van Gerven JM |
---|---|
Zdroj: | Journal of Psychopharmacology; Aug2009, Vol. 23 Issue 6, p625-632, 8p |
Databáze: | Complementary Index |
Externí odkaz: |